VNDA ... Future Pak really wants 'em, ... Future Pak has boosted its acquisition offer for Vanda Pharmaceuticals (NASDAQ:VNDA) to include contingent value rights in addition to the previously announced increased cash consideration of $7.25 to $7.75 per share.
Vanda shares are up ~15% in Tuesday morning trading.
Future Pak said that its latest offer represents a total consideration of $11.62 to $12.12 per share. If full CVRs are exercised, it also represents a premium of 140% to 150% to Vanda's closing price of $4.84 on May 6.
The CVRs are valued at up to $260M, according to Future Pak.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.